Renal Effects of Erythropoietin in Humans

NCT01584921•University of Copenhagen

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Renal Effects

Interventions

Erythropoietin (Epoetin-beta, NeoRecormon®)

+1 more

Locations

Denmark

Locations (1)

Department of Clinical Physiology and Nuclear Medicine and PET, Rigshospitalet

Copenhagen, Copenhagen East, Denmark

Key Dates

Start Date

March 1, 2012

Primary Completion Date

August 1, 2013

Completion Date

September 1, 2013

Last Updated

November 5, 2013

Sponsors

Lead Sponsor

University of Copenhagen

Collaborators

Rigshospitalet, Denmark

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 5, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions